Chong Kun Dang Pharmaceutical (XKRX:185750) Market Cap : ₩1,359,689 Mil (As of Jun. 09, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Chong Kun Dang Pharmaceutical's share price for the quarter that ended in Mar. 2024 was ₩110200. Chong Kun Dang Pharmaceutical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 13 Mil. Therefore, Chong Kun Dang Pharmaceutical's market cap for the quarter that ended in Mar. 2024 was ₩1,404,290 Mil.

Chong Kun Dang Pharmaceutical's quarterly market cap increased from Sep. 2023 (₩1,136,775 Mil) to Dec. 2023 (₩1,586,390 Mil) but then declined from Dec. 2023 (₩1,586,390 Mil) to Mar. 2024 (₩1,404,290 Mil).

Chong Kun Dang Pharmaceutical's annual market cap declined from Dec. 2021 (₩1,247,506 Mil) to Dec. 2022 (₩953,064 Mil) but then increased from Dec. 2022 (₩953,064 Mil) to Dec. 2023 (₩1,586,390 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chong Kun Dang Pharmaceutical's Enterprise Value for Today is ₩1,183,365 Mil.

Chong Kun Dang Pharmaceutical Market Cap Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Market Cap Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

999,864.45

2,448,065.84

1,247,505.74

953,064.00

1,586,390.19

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															942,374.89	997,022.70	1,136,775.18	1,586,390.19	1,404,289.62

Competitive Comparison of Chong Kun Dang Pharmaceutical's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chong Kun Dang Pharmaceutical's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Market Cap distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Market Cap falls into.

Chong Kun Dang Pharmaceutical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Chong Kun Dang Pharmaceutical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	₩130900	*	12.1191
	=	₩1,586,390

Chong Kun Dang Pharmaceutical's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	₩110200	*	12.7431
	=	₩1,404,290

Chong Kun Dang Pharmaceutical (XKRX:185750) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Chong Kun Dang Pharmaceutical Market Cap Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines